Studies have indicated that β-hydroxybutyrate (BHB) can raise the expression of SNTA1 and thus restoring AQP4 polarity in mice models with Alzheimer’s disease. Here, AQP4 is linked to early-onset autosomal dominant Alzheimer disease.